AI/ML Medical Device Action Plan
The CDRH Digital Health Center of Excellence has issued its “Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device Action Plan.” An agency statement (contains a link to the action plan) says the plan is a direct response to stakeholder feedback to a 4/2019 discussion paper on a proposed regulatory framework for modifications to AI/ML software as a medical device. The plan outlines five actions FDA will take:
- further develop the proposed regulatory framework by issuing a draft guidance on a predetermined change control plan;
- support the development of good machine learning practices to evaluate and improve machine learning algorithms;
- foster a patient-centered approach, including device transparency to users;
- develop methods to evaluate and improve machine learning algorithms; and
- advance real-world performance monitoring pilots.